DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Fasudil is an investigational drug.
There have been 12 clinical trials for Fasudil. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2010.
The most common disease conditions in clinical trials are Amyotrophic Lateral Sclerosis, Motor Neuron Disease, and Scleroderma, Diffuse. The leading clinical trial sponsors are Woolsey Pharmaceuticals, Brigham and Women's Hospital, and Shahid Beheshti University of Medical Sciences.
Recent Clinical Trials for Fasudil
|Rho Kinase (ROCK) Inhibitor in Tauopathies - 1||Woolsey Pharmaceuticals||Phase 2|
|Fasudil fOr redUcing elopemeNt and Spatial Disorientation||Woolsey Pharmaceuticals||Phase 2|
|Early Intracoronary Administration of Fasudil in the Primary PCI of ST-segment-Elevation Myocardial Infarction||RenJi Hospital||Phase 4|